Eliquis Discontinuation Before Surgery
For patients on Eliquis (apixaban) for atrial fibrillation, stop the medication 1 day (24 hours) before low-to-moderate bleeding risk procedures and 2 days (48 hours) before high bleeding risk procedures 1.
Risk-Stratified Approach
The duration of preoperative discontinuation depends entirely on the bleeding risk of your planned procedure:
Low-to-Moderate Bleeding Risk Procedures
- Stop Eliquis 1 day before surgery (skip the dose on the day of procedure)
- Last dose should be taken approximately 24 hours prior to the procedure 1
- This applies regardless of renal function for apixaban (unlike dabigatran which requires renal adjustment) 1
High Bleeding Risk Procedures
- Stop Eliquis 2 days before surgery (48 hours minimum)
- Last dose should be taken approximately 48 hours prior to the procedure 1
- The FDA label supports discontinuation "at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding" 2
Key Implementation Points
No bridging anticoagulation is needed. The rapid offset of apixaban (half-life ~12 hours) eliminates the need for heparin bridging with LMWH or UFH 1. Studies demonstrate that bridging increases major bleeding risk 3-4 fold without reducing thromboembolic events 1.
Renal function considerations: Unlike dabigatran, apixaban discontinuation timing does NOT require adjustment based on creatinine clearance 1. The standard 1-2 day protocol applies to all patients, though those with severe renal impairment may have prolonged drug levels 3.
Evidence Quality
This recommendation comes from the 2022 American College of Chest Physicians perioperative anticoagulation guideline 1, which represents the most current high-quality guidance. The FDA label corroborates this approach, specifying 24-48 hour discontinuation windows based on bleeding risk 2. Real-world data from the ADIOS study confirms that 48-hour cessation results in clinically insignificant anticoagulation levels (94% of patients achieved apixaban concentrations ≤30 ng/mL) 4.
Common Pitfalls to Avoid
- Don't stop too early: Unnecessarily prolonged interruption (>2 days for high-risk procedures) increases thromboembolic risk without additional bleeding benefit
- Don't bridge: Perioperative LMWH bridging significantly increases bleeding complications (OR 4.6) without preventing thromboembolism 1
- Don't forget to classify bleeding risk: The entire decision hinges on accurately categorizing your procedure's bleeding risk—consult with your surgeon if uncertain
Resumption After Surgery
Resume Eliquis as soon as adequate hemostasis is established postoperatively 2. The rapid onset of action (peak effect in 3-4 hours) provides quick anticoagulation restoration when clinically appropriate.